- Home
- RHE vs TTNP Comparison
RHE vs TTNP Comparison
Compare RHE & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RHE
- TTNP
- Stock Information
- Founded
- RHE 1988
- TTNP 1991
- Country
- RHE United States
- TTNP United States
- Employees
- RHE N/A
- TTNP N/A
- Industry
- RHE Real Estate
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RHE Real Estate
- TTNP Health Care
- Exchange
- RHE Nasdaq
- TTNP Nasdaq
- Market Cap
- RHE 3.5M
- TTNP 3.7M
- IPO Year
- RHE 2006
- TTNP 1996
- Fundamental
- Price
- RHE $1.57
- TTNP $3.81
- Analyst Decision
- RHE
- TTNP
- Analyst Count
- RHE 0
- TTNP 0
- Target Price
- RHE N/A
- TTNP N/A
- AVG Volume (30 Days)
- RHE 27.3K
- TTNP 8.5K
- Earning Date
- RHE 11-29-2024
- TTNP 11-29-2024
- Dividend Yield
- RHE N/A
- TTNP N/A
- EPS Growth
- RHE N/A
- TTNP N/A
- EPS
- RHE N/A
- TTNP N/A
- Revenue
- RHE $15,936,000.00
- TTNP $3,000.00
- Revenue This Year
- RHE N/A
- TTNP N/A
- Revenue Next Year
- RHE N/A
- TTNP N/A
- P/E Ratio
- RHE N/A
- TTNP N/A
- Revenue Growth
- RHE N/A
- TTNP N/A
- 52 Week Low
- RHE $1.13
- TTNP $3.57
- 52 Week High
- RHE $3.08
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- RHE 43.01
- TTNP 34.23
- Support Level
- RHE $1.13
- TTNP $3.77
- Resistance Level
- RHE $2.11
- TTNP $4.66
- Average True Range (ATR)
- RHE 0.15
- TTNP 0.28
- MACD
- RHE -0.04
- TTNP 0.04
- Stochastic Oscillator
- RHE 44.90
- TTNP 3.93
About RHE Regional Health Properties Inc.
Regional Health Properties Inc is a self-managed healthcare real estate investment company that invests in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transactions. It has two reportable segments real estate segment and the healthcare services segment. It derives the majority of its revenue from the healthcare services segment. Its portfolio of properties is diversified across various states, with concentrations in Georgia and Ohio.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.